Manufacturing method for intravenous immune globulin and resultant product

摘要

A continuous process for producing an intravenously-administrable gamma globulin solution substantially free of contaminating viruses by heat treating a gamma globulin solution for viral inactivation, fractionating to obtain a purified gamma globulin solution without precipitation of the desired gamma globulin and then treating the purified gamma globulin with a solvent-detergent for further viral inactivation. Partially purified gamma globulin solids is not recovered as an intermediate product during the disclosed process.